Skip to main navigation Skip to search Skip to main content

Identification of new common predictive biomarkers to stratify TNBC breast cancer patients for treatment with emerging immune checkpoints

Project Details

AcronymINCOM (RCMS-2020)
StatusFinished
Effective start/end date15/10/201/01/22

Funding

  • Fondation de Recherche Cancer et Sang: €55,626.00